Gut microbiota in adolescents and the association with fatty liver: the EPOCH study

Pediatric Research

Volumn 84, Issue 2, 2018, Pages 219-227

  Stanislawski, Maggie A ^a   Lozupone, Catherine A ^b   Wagner, Brandie D ^a   Eggesbø, Merete ^c   Sontag, Marci K ^a   Nusbacher, Nichole M ^b   Martinez, Mercedes ^a   Dabelea, Dana ^a  

^a Food Science and Human Nutrition   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADOLESCENT; BODY MASS; CHILD; COMORBIDITY; DIAGNOSTIC IMAGING; DIET; FECES; FEMALE; GENETICS; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LIVER; MALE; MICROBIOLOGY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PROSPECTIVE STUDY; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; BODY MASS INDEX; CHILD; COMORBIDITY; DIET; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE IMAGING; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85052298458     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2018.32     Document Type: Article

References (40)

1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013;10:686–690
2. Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 2009;8:S4–S8
3. Ali R, Cusi K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Ann Med 2009;41:265–278
4. DeVore S, Kohli R, Lake K et al. A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD. J Pediatr Gastroenterol Nutr 2013;57:119–123
5. Boursier J, Diehl AM. Implication of Gut microbiota in nonalcoholic fatty liver disease. PLoS Pathog 2015;11:e1004559
6. Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol 2016;13:412–425
7. Finelli C, Tarantino G. Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients. J Gastrointestin Liver Dis 2012;21:293–302
8. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 2015;11:577
9. Tarantino G, Finelli C. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. Future Microbiol 2015;10:889–902
10. Hussain HK, Chenevert TL, Londy FJ et al. Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology 2005;237:1048–1055
11. Hussain HK, Oral EA, Rohrer S et al. Validation of hepatic fat quantified on 3 T MRI via histopathologic correlation in patients with non-alcoholic steatohepatitis. Proc Int Soc Magn Reson Med Sci Meet Exhib Int Soc Magn Reson Med Sci Meet Exhib 16 2008;713
12. Rastogi R, Gupta S, Garg B, Vohra S, Wadhawan M, Rastogi H. Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors. Indian J Radiol Imaging 2016;26:5–14
13. Block G, Murphy M, Roullet J, Wakimoto P Pilot validation of a FFQ for children 8-10 years. Fourth International Conference on Dietary Assessment Methods, Tucson, AZ, USA, 2000
14. Crume TL, Scherzinger A, Stamm E et al. The long-term impact of intrauterine growth restriction in a diverse US cohort of children: The EPOCH study. Obesity 2014;22:608–615
15. Centers for Disease Control and Prevention SAS Program (ages 0 to<20 years) ∣ Resources ∣ Growth Chart Training ∣ Nutrition ∣ DNPAO ∣ CDC [Internet]. Growth Chart Train (cited 6 Jan 2017) https://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas.htm
16. CDC Defining Childhood Overweight & Obesity [Internet] (cited 14 Mar 2017) https://www.cdc.gov/obesity/childhood/defining.html
17. Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES) Anthropometry procedures manual [Internet], 2007 (cited 8 Dec 2017) https://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/manual_an.pdf
18. Crume TL, Ogden L, Daniels S, Hamman RF, Norris JM, Dabelea D. The impact of in utero exposure to diabetes on childhood body mass index growth trajectories: The EPOCH Study. J Pediatr 2011;158:941–946
19. R Core Team R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing, 2016 https://www.R-project.org/
20. Caporaso JG, Kuczynski J, Stombaugh J et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335–336
21. DeSantis TZ, Hugenholtz P, Larsen N et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069–5072
22. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26:2460–2461
23. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. ISME J 2011;5:169
24. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207–214
25. Friedman J, Hastie T, Tibshirani R. Sparse inverse covariance estimation with the graphical lasso. Biostatistics 2008;9:432–441
26. Zhu L, Baker SS, Gill C et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013;57:601–609
27. Del Chierico F, Nobili V, Vernocchi P et al. Gut microbiota profiling of pediatric NAFLD and obese patients unveiled by an integrated meta-omics based approach. Hepatology 2016;65:451–464
28. Sze MA, Schloss PD. Looking for a signal in the noise: revisiting obesity and the microbiome. mBio 2016;7:e01018–16
29. Poeta M, Pierri L, Vajro P. Gut–liver axis derangement in non-alcoholic fatty liver disease. Children 2017;4:66
30. Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the Gut microbiome. Curr Opin Gastroenterol 2014;30:332–338
31. Hardison WG. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 1978;75:71–75
32. Devkota S, Wang Y, Musch M et al. Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice. Nature 2012;487:104–108
33. O’Keefe SJD, Li JV, Lahti L et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun 2015;6:6342
34. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105–108
35. David LA, Maurice CF, Carmody RN et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559–563
36. Konikoff T, Gophna U. Oscillospira: a central, enigmatic component of the human gut microbiota. Trends Microbiol 2016;24:523–524
37. Yatsunenko T, Rey FE, Manary MJ et al, Human gut microbiome viewed across age and geography. Nature [Internet], 2012 (cited 14 Apr 2014) http://www.nature.com/doifinder/10.1038/nature11053
38. Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 2014;588:4223–4233
39. Byers T. Food frequency dietary assessment: how bad is good enough? Am J Epidemiol 2001;154:1087–1088
40. Maier TV, Lucio M, Lee LH et al. Impact of dietary resistant starch on the human gut microbiome, Metaproteome, and Metabolome. MBio 2017;8:e01343–17